Whether individuals exhibit consistent behavioural variation is a central question in the field of animal behaviour. This question is particularly interesting in the case of social animals, as their behaviour may be strongly modulated by the collective. In this study, we ask whether honeybees exhibit individual differences in stinging behaviour. We demonstrate that bees are relatively stable in their decision to sting-or not-in a specific context and show temporal consistency suggestive of an internal state modulation. We also investigated how social factors such as the alarm pheromone or another bee modulated this behaviour. The presence of alarm pheromone increased the likelihood of a bee to sting but this response decayed over trials, while the presence of a conspecific decreased individual stinging likelihood. These factors, however, did not alter stinging consistency. We therefore propose that social modulation acts by shifting the stinging threshold of individuals. Finally, experimental manipulation of group composition with respect to the ratio of aggressive and gentle bees within a group did not affect the behaviour of focal bees. Overall, our results establish honeybee stinging behaviour as a promising model for studying mechanistically how collective and individual traits interact to regulate individual variability.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774586 | PMC |
http://dx.doi.org/10.1098/rsos.241295 | DOI Listing |
R Soc Open Sci
January 2025
Department of Biology, University of Konstanz, Konstanz, Germany.
Whether individuals exhibit consistent behavioural variation is a central question in the field of animal behaviour. This question is particularly interesting in the case of social animals, as their behaviour may be strongly modulated by the collective. In this study, we ask whether honeybees exhibit individual differences in stinging behaviour.
View Article and Find Full Text PDFFront Immunol
January 2025
Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
The innate immune system promptly detects and responds to invading pathogens, with a key role played by the recognition of bacterial-derived DNA through pattern recognition receptors. The Z-DNA binding protein 1 (ZBP1) functions as a DNA sensor inducing type I interferon (IFN) production, innate immune responses and also inflammatory cell death. ZBP1 interacts with cytosolic DNA via its DNA-binding domains, crucial for its activation.
View Article and Find Full Text PDFHeliyon
January 2025
Department of Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, Jiangsu, China.
Melatonin (Mel) is known for various biological function, such as antioxidant and anti-inflammatory capabilities, as well as its ability to modulate immune responses, which can protect mitochondria and improve the prognosis of sepsis-associated acute kidney injury (SA-AKI). However, there is a multitude of theories regarding how Mel exerts its immune-modulating functions, with no consensus reached as of yet. We propose the protective effects of Mel on mitochondria are closely related to the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling pathway in the immune-inflammatory response.
View Article and Find Full Text PDFImmunol Res
January 2025
, Auckland, New Zealand.
Cytotoxic DNAs, methylation, histones and histones binding proteins are speculated to induce DNA sensors. Under stressed condition, the antigenic patterns, PAMPs and DAMPs, trigger the hyperactive innate response through DNA, DNA-RNA hybrids, oligonucleotides, histones and mtDNA to initiate cGAMP-STING-IFN I cascade. HSV -1&2, HIV, Varicella- Zoster virus, Polyomavirus, Cytomegalovirus, and KSHV negatively regulate the STING-MAVS-TBK-1/1KKE pathway.
View Article and Find Full Text PDFThis study investigates the synergistic inhibitory effects of combining the stimulator of interferon genes (STING) agonist cyclic diadenylate monophosphate (c-di-AMP) and ginsenoside RG3 on cisplatin (DDP)-resistant gastric cancer (GC) cells. The objective is to identify novel therapeutic targets and offers insights for the clinical management of DDP resistance. Various techniques were employed, including western blot, MTT assay, colony formation assay, scratch assay, transwell assay, tubule formation assay, flow cytometry, Hoechst 33342 fluorescence staining, and in vivo experiments, to investigate the potential mechanisms and effects of the combined application of the STING agonist and ginsenoside RG3 in reversing cisplatin resistance in gastric cancer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!